Evidence for the use of HDAC6 inhibitors to prevent aggresome formation can be found from studies demonstrating that siRNA silencing of HDAC6 abolishes aggresome formation in pancreatic cancer cells.41 This evidence concerns the gene HDAC6 and familial pancreatic carcinoma.